Skip to main content
HR 1776 115th Congress House Health Administrative law and regulatory procedures Administrative remedies Business records Canada Cancer Civil actions and liability Competition and antitrust Congressional oversight Consumer affairs Corporate finance and management Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Executive agency funding and structure Federal Trade Commission (FTC) Government information and archives Government studies and investigations Government trust funds Health care costs and insurance

Improving Access To Affordable Prescription Drugs Act

Introduced: November 1, 2017 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 5, 2017
Referred to the Subcommittee on Health.
Mar 31, 2017
Referred to the Subcommittee on Health.
Mar 29, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 29, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill amends provisions of various laws relating to prescription-drug pricing and affordability. Specifically, the bill:

  • expands reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance;
  • adds reporting requirements for certain nonprofit patient-assistance programs;
  • requires the Government Accountability Office (GAO) to report to Congress on the impact of patient-assistance programs on prescription-drug pricing and expenditures;
  • requires the Centers for Medicare & Medicaid Services (CMS) to negotiate prices for certain prescription drugs under the Medicare program;
  • requires the GAO to report to Congress on such negotiations conducted by the CMS;
  • requires the Centers for Medicare and Medicaid Innovation within the CMS to test specified models for negotiating drug prices;
  • establishes reporting requirements, and corresponding civil penalties for noncompliance, for pharmaceutical companies with respect to spikes in prescription-drug prices;
  • establishes an excise tax on prescription drugs subject to price spikes;
  • lessens prescription-drug cost-sharing requirements under qualified health plans, group health plans, and the Medicare program;
  • modifies provisions related to the importation of prescription drugs;
  • requires drug manufacturers to provide drug rebates for drugs dispensed to certain low-income individuals under the Medicare program;
  • establishes a prize fund for new and more effective treatments of bacterial infections;
  • establishes a Center for Clinical Research within the National Institutes of Health;
  • modifies provisions related to drug exclusivity;
  • allows the Federal Trade Commission to initiate enforcement proceedings against parties to an agreement resolving or settling a patent-infringement claim in connection with the sale of a drug product;
  • requires the Food and Drug Administration to establish a database of generic drugs; and
  • modifies other provisions related to generic drugs, prescription-drug advertising, and product hopping.
What's happening now April 5, 2017

Referred to the Subcommittee on Health.

 Related & companion bills 10
  • HR 6340 Related bill Capping Prescription Costs Act of 2018
  • S 252 Related bill Medicare Drug Savings Act of 2017
  • S 348 Related bill Prescription Drug and Health Improvement Act of 2017
  • S 469 Related bill Affordable and Safe Prescription Drug Importation Act
  • S 2478 Related bill End Taxpayer Subsidies for Drug Ads Act
  • HR 1245 Related bill Affordable and Safe Prescription Drug Importation Act
  • S 2476 Related bill Expanding Access to Low Cost Generic Drugs Act
  • S 1688 Related bill Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
  • S 771 Identical bill Improving Access To Affordable Prescription Drugs Act
  • S 3411 Related bill Affordable Medications Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 12
All 12 Democratic 11
D
Khanna, Ro
California · Jul 25, 2018
 D
Norton, Eleanor Holmes
District of Columbia · May 21, 2018
VISCLOSKY, PETER
· Nov 1, 2017
 D
Jayapal, Pramila
Washington · Sep 6, 2017
 D
McCollum, Betty
Minnesota · Jul 26, 2017
 D
Cohen, Steve
Tennessee · Jun 23, 2017
 D
Chu, Judy
California · Jun 6, 2017
 D
Pingree, Chellie
Maine · May 18, 2017
 D
Barragán, Nanette Diaz
California · Apr 25, 2017
 D
Pocan, Mark
Wisconsin · Apr 5, 2017
 D
DeLauro, Rosa L.
Connecticut · Mar 29, 2017
 D
Welch, Peter
Vermont · Mar 29, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1776: Improving Access To Affordable Prescription Drugs Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1776/
MLA
"H.R. 1776: Improving Access To Affordable Prescription Drugs Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1776/.
Bluebook (legal)
H.R. 1776, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1776/.
Markdown link
[H.R. 1776: Improving Access To Affordable Prescription Drugs Act](https://openamerica.io/bill/115-HR-1776/)
Report a problem